Citizens National Bank Trust Department’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Citizens National Bank Trust Department’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-348	Closed	-$40.3K	–	325
2023 Q3	$40.3K	Hold	348	–	–	0.01%	215
2023 Q2	$35.8K	Hold	348	–	–	0.01%	224
2023 Q1	$38K	Hold	348	–	–	0.01%	219
2022 Q4	$40K	Hold	348	–	–	0.01%	210
2022 Q3	$22K	Hold	348	–	–	0.01%	245
2022 Q2	$28K	Hold	348	–	–	0.01%	233
2022 Q1	$34K	Hold	348	–	–	0.01%	214
2021 Q4	$38K	Buy	+348	New	+$38K	0.01%	210

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citizens National Bank Trust Department's HZNP Position: Q4 2023 in Review

Citizens National Bank Trust Department sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 348 shares — an estimated $40.3K sold.

Citizens National Bank Trust Department first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $40.3K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Citizens National Bank Trust Department reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Citizens National Bank Trust Department sold 348 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.3K.
Citizens National Bank Trust Department first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
Citizens National Bank Trust Department's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $40.3K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Citizens National Bank Trust Department's 13F filing for Q4 2023, filed 29 Jan 2024.